Featured Publications
Long-term outcomes from a multi-institutional experience with prefabricated composite gracilis-buccal mucosal flap for reconstruction of devastated urethras
Sterling J, Schardein J, Joshi PM, Kulkarni SB, Nikolavsky D. Long-term outcomes from a multi-institutional experience with prefabricated composite gracilis-buccal mucosal flap for reconstruction of devastated urethras. International Urology And Nephrology 2022, 54: 1047-1052. PMID: 35247151, DOI: 10.1007/s11255-022-03154-z.Peer-Reviewed Original ResearchConceptsPatient-reported outcome measuresGlobal response assessmentBuccal mucosal graftOutcome measuresMulti-institutional retrospective reviewSecondary outcome measuresPrimary outcome measureLong-term outcomesMulti-institutional experiencePost-operative surveyStage 2 repairStage 1Mean IPSSMean PVRStricture lengthCase seriesResultsFive patientsRetrospective reviewStricture recurrenceSuprapubic tubeSurgical optionsBulbar urethraMean ageMucosal graftPerineal urethrostomy
2022
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
Kim IY, Mitrofanova A, Panja S, Sterling J, Srivastava A, Kim J, Kim S, Singer EA, Jang TL, Ghodoussipour S, Saraiya B, Mayer T, Sabaawy HE, Yuh B, Byun SS, Kim WJ, Horie S. Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate International 2022, 10: 75-79. PMID: 35510081, PMCID: PMC9035380, DOI: 10.1016/j.prnil.2022.03.001.Peer-Reviewed Original ResearchCytoreductive radical prostatectomyPhase 1 clinical trialLong-term outcomesProstate cancerRadical prostatectomyOncologic outcomesSystemic therapyClinical trialsMulticenter phase 1 trialLong-term oncologic outcomesAndrogen deprivation therapyPrimary end pointEvidence of diseaseMajor complication rateCombination of surgeryMajor inclusion criteriaPhase 1 trialMetastatic prostate cancerB prostate cancerTumor necrosis factorLong-term useMinority of menDeprivation therapyM1 diseaseClavien-Dindo